-
161
-
162
-
163
Local staging and treatment in extremity rhabdomyosarcoma. A report from the EpSSG‐RMS2005 study
Published 2020-10-01Get full text
Article -
164
-
165
-
166
-
167
Minimal Residual Disease Monitoring in Radically Treated Non-Small Cell Lung Cancer: Challenges and Future Directions
Published 2023-04-01“…Hazel M O’Sullivan,1 Andrew Feber,2 Sanjay Popat1– 3 1Lung Unit, Royal Marsden NHS Foundation Trust, London, UK; 2The Institute of Cancer Research, London, UK; 3National Heart and Lung Institute, Imperial College London, London, UKCorrespondence: Sanjay Popat, The Lung Unit, The Royal Marsden Hospital, London, SW3 6JJ, United Kingdom, Tel +442073528171, Email sanjay.popat@rmh.nhs.ukAbstract: Circulating tumor DNA (ctDNA) analysis can identify patients with residual disease before it is clinically or radiologically evident. …”
Get full text
Article -
168
Extensive mucocutaneous, oesophageal and otic lichen planus secondary to nivolumab therapy
Published 2021-03-01Get full text
Article -
169
-
170
-
171
-
172
Anaplastic lymphoma kinase-positive pulmonary inflammatory myofibroblastic tumour: a case report
Published 2024-04-01Get full text
Article -
173
-
174
-
175
-
176
-
177
-
178
Radiation therapy in the adjuvant treatment of hyperkeratotic palmoplantar psoriasis: a case study
Published 2021-09-01Get full text
Article -
179
-
180